Citations

Clear

3057 citation(s) found for "Cd, Johnson".

Barriers to neurosurgery for medical students: a national study focused on the intersectionality of gender and race
Pugazenthi, Sangami , Malacon, Karen , Kim, Nora C. , Stuebe, Caren , Yoh, Nina , Walker, Erin Jackson, Becker, Kathryn N. , Johnson, Gabrielle W. , Caston, Rose M. , Lee, Hedwig, Strahle, Jennifer M. , Bhanja, Debarati , Walker, Erin, Bauman, Megan M. J. , Ben‐Haim, Sharona

Mayo Clinic

Journal of Neurosurgery | May 18, 2024 | Volume: 141 | Issue: 5 | Pages: 1395-1406

10.3171/2024.2.jns232038 | PMID 38759239 Get It

OBJECTIVE Despite 51.2% of medical school graduates being female, only 29.8% of neurosurgery residency applicants are female. Furthermore, only 12.6% of neurosurgery applicants identify as underrepresented in medicine (URM). Evaluating the entry barriers for female and URM students is crucial in promoting the equity and diversity of the neurosurgical workforce. The objective of this study was to evaluate barriers to neurosurgery for medical students while considering the interaction between gender and race. METHODS A Qualtrics survey was distributed widely to US medical students, assessing 14 factors of hesitancy toward neurosurgery. Likert scale responses, representing statement agreeability, converted to numeric values on a 7-point scale were analyzed by Mann-Whitney U-test and ANOVA comparisons with Bonferroni correction. RESULTS Of 540 respondents, 68.7% were female and 22.6% were URM. There were 22.6% male non-URM, 7.4% male URM, 53.5% female non-URM, and 15.2% female URM respondents. The predominant reasons for hesitancy toward neurosurgery included work/life integration, length of training, competitiveness of residency position, and perceived malignancy of the field. Females were more hesitant toward neurosurgery due to maternity/paternity needs (p = 0.005), the absence of seeing people like them in the field (p < 0.001), and opportunities to pursue health equity work (p < 0.001). Females were more likely to have difficulties finding a mentor in neurosurgery who represented their identities (p = 0.017). URM students were more hesitant toward neurosurgery due to not seeing people like them in the field (p < 0.001). Subanalysis revealed that when students were stratified by both gender and URM status, there were more reasons for hesitancy toward neurosurgery that had significant differences between groups (male URM, male non-URM, female URM, and female non-URM students), suggesting the importance of intersectionality in this analysis. CONCLUSIONS The authors highlight the implications of gender and racial diversity in the neurosurgical workforce on medical student interest and recruitment. Their findings suggest the importance of actively working to address these barriers, including 1) maternity/paternity policy reevaluation, standardization, and dissemination; and 2) actively providing resources for the creation of mentorship relationships for both women and URM students in an effort to create a workforce that aligns with the changing demographics of medical graduates to continue to improve diversity in neurosurgery.
Ventilatory Assistance Before Umbilical Cord Clamping in Extremely Preterm Infants
Petroni, Gina R. , Varhegyi, Nikole, Strand, Marya L. , Josephsen, Justin , Niermeyer, Susan , Barry, James S. , Fang, Jennifer L. , Thomas, Sumesh , Kane, Andrea F., Byrne, Bobbi J., Underwood, Mark A. , Poulain, Francis R., Law, Brenda Hiu Yan , Gorman, Terri, Leone, Tina A. , Bulas, Dorothy , Epelman, Mónica , Chisholm, Christian A., Kattwinkel, John, Duda, Gina M, Thielen, Monika, Liedl, Lavonne M., Amsbaugh, Amy, Lamprecht, Amy, Berlinski, Carolyn S, Johnson, Jacque-Lynne F, Irvine, Leigh , Ciorogariu-Ivan, Anna-Maria, Pesavento, Rosa R, Fray, Caroline , Athaide, Melba, Fairchild, Karen D. , Warren, Jamie B. , Rincon, Monica P. , Travers, Colm P. , Carlo, Waldemar A. , Kline‐Fath, Beth M. , Hawkins, Melissa, Ciorogariu‐Ivan, Anna‐Maria

Mayo Clinic

JAMA Network Open | May 17, 2024 | Volume: 7 | Issue: 5 | Pages: e2411140

10.1001/jamanetworkopen.2024.11140 | PMID 38758557 Get It

ImportanceProviding assisted ventilation during delayed umbilical cord clamping may improve outcomes for extremely preterm infants.ObjectiveTo determine whether assisted ventilation in extremely preterm infants (23 0/7 to 28 6/7 weeks’ gestational age [GA]) followed by cord clamping reduces intraventricular hemorrhage (IVH) or early death.Design, Setting, and ParticipantsThis phase 3, 1:1, parallel-stratified randomized clinical trial conducted at 12 perinatal centers across the US and Canada from September 2, 2016, through February 21, 2023, assessed IVH and early death outcomes of extremely preterm infants randomized to receive 120 seconds of assisted ventilation followed by cord clamping vs delayed cord clamping for 30 to 60 seconds with ventilatory assistance afterward. Two analysis cohorts, not breathing well and breathing well, were specified a priori based on assessment of breathing 30 seconds after birth.InterventionAfter birth, all infants received stimulation and suctioning if needed. From 30 to 120 seconds, infants randomized to the intervention received continuous positive airway pressure if breathing well or positive-pressure ventilation if not, with cord clamping at 120 seconds. Control infants received 30 to 60 seconds of delayed cord clamping followed by standard resuscitation.Main Outcomes and MeasuresThe primary outcome was any grade IVH on head ultrasonography or death before day 7. Interpretation by site radiologists was confirmed by independent radiologists, all masked to study group. To estimate the association between study group and outcome, data were analyzed using the stratified Cochran-Mantel-Haenszel test for relative risk (RR), with associations summarized by point estimates and 95% CIs.ResultsOf 1110 women who consented to participate, 548 were randomized and delivered infants at GA less than 29 weeks. A total of 570 eligible infants were enrolled (median [IQR] GA, 26.6 [24.9-27.7] weeks; 297 male [52.1%]). Intraventricular hemorrhage or death occurred in 34.9% (97 of 278) of infants in the intervention group and 32.5% (95 of 292) in the control group (adjusted RR, 1.02; 95% CI, 0.81-1.27). In the prespecified not-breathing-well cohort (47.5% [271 of 570]; median [IQR] GA, 26.0 [24.7-27.4] weeks; 152 male [56.1%]), IVH or death occurred in 38.7% (58 of 150) of infants in the intervention group and 43.0% (52 of 121) in the control group (RR, 0.91; 95% CI, 0.68-1.21). There was no evidence of differences in death, severe brain injury, or major morbidities between the intervention and control groups in either breathing cohort.Conclusions and RelevanceThis study did not show that providing assisted ventilation before cord clamping in extremely preterm infants reduces IVH or early death. Additional study around the feasibility, safety, and efficacy of assisted ventilation before cord clamping may provide additional insight.Trial RegistrationClinicalTrials.gov Identifier: NCT02742454
Glomerular Complement Proteins in Thrombotic Microangiopathy
Johnson, Kenneth L. , Charlesworth, M. Cristine , Sethi, Sanjeev , Palma, Lilian Monteiro P , Sridharan, Meera , Madden, Benjamin J.

Mayo Clinic

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 31 | Issue: 10S | Pages: 546-546

10.1681/asn.20203110s1546d Get It

Multimodality imaging for acquired supravalvular aortic stenosis
Alsidawi, Said , Nkomo, Vuyisile T. , Wang, George, Nkomo, Vuyisile T , Alsidawi, Said , Lee, Kwan , Wang, George C.

Mayo Clinic

European Heart Journal - Cardiovascular Imaging | May 14, 2024 | Volume: 25 | Issue: 10 | Pages: e254-e254

10.1093/ehjci/jeae128 | PMID 38742633 Get It

The Clinical Utility of a Chemokine-Cytokine Multiplex Assay in Fibromyalgia Diagnosis at an Academic Medical Center
Mohabbat, Arya B. , Wight, Elizabeth C. , Johnson, Tammi R., McCarthy, Page E., Aakre, Christopher A. , Bornstein, Shari L. , Salonen, Bradley R. , Bierle, Dennis M. , Johnson, Tammi R., Ganesh, Ravindra

Mayo Clinic

No container title available | May 13, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-4145257/v1 Get It

Abstract Introduction/Objective: To assess the clinical utility of the FM/a® chemokine-cytokine assay in diagnosing fibromyalgia at an academic medical center. Methods: We performed a cross-sectional study on 50 patients diagnosed with fibromyalgia at a specialty fibromyalgia clinic between January 1, 2021 through July 31, 2021. Patients completed questionnaires and provided a venous blood sample sent to EpicGenetics, to complete the FM/a® test. Demographic, symptom, and historical data was obtained from chart review. Statistical analysis was performed. Results: Of 50 patients with a clinical diagnosis of fibromyalgia, the FM/a® test was positive in 45 (90%). Performance of the FM/a® test compared to the 2016 ACR criteria yielded an odds ratio of 3.5 with sensitivity of 0.91, specificity of 0.25. Univariate regression demonstrated an area under the curve (AUC) of 0.7337, which improved to 0.89 when adjusted for age, gender, and race. When compared to the 1990 ACR criteria, a positive FM/a® test had an odds ratio of 2.33 with sensitivity 0.92 and specificity 0.17. Univariate regression analysis demonstrated an AUC of 0.571, when adjusted for age, gender and race, AUC was similar at 0.585. Conclusion: The FM/a® test performed well overall, though inferiorly compared to the 1990 and 2016 ACR diagnostic criteria. When adjusted for age, gender, and race the test performed almost equivalently to the 2016 ACR criteria. The FM/a® test may be useful in general clinical practices to differentiate patients who are more likely to have FM.
Interbody cages versus structural bone grafts in lumbar arthrodesis: a systematic review and meta-analysis
Johnson, Sarah E. , Freedman, Brett A. , Bydon, Mohamad , Flanigan, Patrick M, Katsos, Konstantinos, Michalopoulos, Giorgos D. , Flanigan, Patrick Michael , Katsos, Konstantinos, Ibrahim, Sufyan

Mayo Clinic

Journal of Neurosurgery: Spine | May 11, 2024 | Volume: 41 | Issue: 2 | Pages: 188-198

10.3171/2024.2.spine23940 | PMID 38728766 Get It

OBJECTIVE The role of interbodies in lumbar arthrodesis has been insufficiently supported by evidence, impacting clinical decision-making and occasionally insurance coverage. This study aimed to compare clinical and radiological outcomes between lumbar arthrodesis with a synthetic interbody spacer (cage) versus structural bone graft alone (autograft or allograft) in patients with degenerative spine disease. METHODS A systematic review of the literature was performed to identify studies directly comparing outcomes of lumbar interbody arthrodesis with and without interbody cage use. The outcomes of individual studies were synthesized in meta-analyses using random-effects models. RESULTS Twenty studies with 1508 patients (769 with an interbody cage and 739 without an interbody cage) were included. Interbody cage placement was associated with a significantly greater increase in disc height after surgery (4.0 mm vs 3.4 mm, p < 0.01). There was a significantly greater reduction of back pain (visual analog scale [VAS] score) in cases in which an interbody cage was used (5.4 vs 4.7, p = 0.03). Fusion rates were 5.5% higher in the cage group (96.3% vs 90.8%) and reached statistical significance (p = 0.03). No statistically significant differences were identified between the two groups regarding all-cause reoperation rates, complication rates, or improvement in Oswestry Disability Index score or leg pain (VAS score). CONCLUSIONS These results suggest that implantation of an interbody cage is associated with higher rates of fusion, more effective maintenance of disc height, and greater improvement of back pain. This study underlines the clinical value of interbody cages in lumbar arthrodesis for patients with degenerative spine disease.
A review of mitotane in the management of adrenocortical cancer
Rivero, Jaydira Del , Else, Tobias , Hallanger‐Johnson, Julie , Kiseljak‐Vassiliades, Katja , Raj, Nitya , Reidy‐Lagunes, Diane , Srinivas, Sandy, Gilbert, Jill, Vaidya, Anand , Aboujaoude, Emily , Fojo, Tito , Del Rivero, Jaydira , Bancos, Irina , Tito Fojo, Antonio , Bancos, Irina

Mayo Clinic

The Oncologist | May 9, 2024 | Volume: 29 | Issue: 9 | Pages: 747-760

10.1093/oncolo/oyae084 | PMID 39037424 Get It

Abstract Importance Mitotane (Lysodren, o,p'-DDD [1-(o-chlorophenyl)-1-(p-chlorophenyl)-2,2-dichloroethane)] is currently the only United States Food and Drug Administration and European Medicines Agency-approved product for the treatment of adrenocortical carcinoma. Observations Mitotane is challenging to administer; however, its toxicities (specifically adrenal insufficiency) are well known, and the management of adverse consequences has established approaches. While often viewed through the prism of a cytotoxic agent, it can also interfere with hormone production making it a valuable asset in managing functional ACC. A recently completed prospective trial has shed some light on its use in the adjuvant setting, but further clarity is needed. Many think mitotane has a role in the advanced or metastatic setting, although prospective data are lacking and retrospective analyses are often difficult to interpret. Conclusions and relevance When used carefully and thoughtfully, especially in patients with hormonal excess, mitotane is an important component of the treatment armamentarium for ACC.
Long‐term pneumatic stenting with positive expiratory pressure therapy for severe expiratory central airway collapse
Funes‐Ferrada, Rodrigo , Lee‐Mateus, Alejandra Yu , Johnson, Margaret M. , Fernández-Bussy, Sebastián , Barrios-Ruiz, Alanna, Yu Lee-Mateus, Alejandra , Fernandez-Bussy, Sebastian , Barrios‐Ruiz, Alanna , Abia‐Trujillo, David

Mayo Clinic

Respirology Case Reports | May 9, 2024 | Volume: 12 | Issue: 5 | Pages: No page available

10.1002/rcr2.1367 | PMID 38725709 Get It

AbstractExpiratory central airway collapse (ECAC) comprising excessive central airway collapse (EDAC) and tracheobronchomalacia. Treatment is challenging for severe cases that are not candidates for surgical management. We report a case of severe ECAC successfully managed with continuous positive airway pressure (CPAP) therapy. A 75‐year‐old female patient status post right pneumonectomy, presented with chronic cough. Dynamic bronchoscopy evaluation showed severe EDAC which improved with intraprocedural noninvasive positive pressure (NIPPV) therapy. Due to patients' comorbidities, she was not a candidate to surgical tracheobronchoplasty. Therefore, we attempted pneumatic stenting with long‐term CPAP therapy resulting in improvement of symptoms and functional capacity. The long‐term efficacy of pneumatic stenting has not been clearly established yet. Literature review of management of ECAC with NIPPV consist primarily of case reports and there is only one clinical trial being conducted to assess the efficacy of CPAP therapy in ECAC. While NIPPV arises as a sufficient alternative for management of severe ECAC, larger scale studies are needed to prove the real efficacy of NIPPV in this setting.
Bone morphogenetic protein in subaxial cervical arthrodesis: a meta-analysis of 5828 patients
Johnson, Sarah E. , Sebastian, Arjun S. , Freedman, Brett A. , Bydon, Mohamad , Katsos, Konstantinos, Ibrahim, Sufyan , Michalopoulos, Giorgos D. , Flanigan, Patrick Michael , Katsos, Konstantinos

Mayo Clinic

Journal of Neurosurgery: Spine | May 4, 2024 | Volume: 41 | Issue: 2 | Pages: 174-187

10.3171/2024.2.spine23941 | PMID 38701518 Get It

OBJECTIVE Use of bone morphogenetic protein (BMP)—an osteoinductive agent commonly used in lumbar arthrodesis—is off-label for cervical arthrodesis. This study aimed to identify the effect of BMP use on clinical and radiological outcomes in instrumented cervical arthrodesis. METHODS A comprehensive systematic review of the literature was performed to identify studies directly comparing outcomes between cervical arthrodeses with and without using BMP. Outcomes were analyzed separately for cases of anterior cervical discectomy and fusion (ACDF) and posterior cervical fusion (PCF). RESULTS A total of 20 studies with 5828 patients (1948 with BMP and 3880 without BMP) were included. In the ACDF cases, BMP use was associated with higher fusion rates (98.9% vs 93.6%, risk difference [RD] 8%; risk ratio [RR] 1.12, p = 0.02), lower reoperation rates (2.2% vs 3.1%, RD 3%; RR 0.48, p = 0.04), and higher risk of dysphagia (24.7% vs 8.1%, RD 11%; RR 1.93, p = 0.02). No significant differences in the Neck Disability Index, neck pain, or arm pain scores were associated with the use of BMP. On subgroup meta-analysis of ACDF cases, older age (≥ 50 years) and higher BMP dose (≥ 0.9 mg/level) were associated with significantly higher fusion rates and relatively lower risk for dysphagia, whereas arthrodesis of fewer segments (< 2 levels) showed significantly higher dysphagia rates without a significant increase in fusion rates. In the PCF cases, the use of BMP was not associated with significant differences in fusion (p = 0.38) or reoperation (p = 0.61) rates but was associated with significantly higher blood loss during surgery (mean difference 146.7 ml, p ≤ 0.01). CONCLUSIONS Use of BMP in ACDF offers higher rates of augmented fusion and lower rates of all-cause reoperation but with an increased risk of dysphagia. The benefit of fusion outweighs the risk of dysphagia with a higher BMP dose in older patients being operated on for < 2 levels. The use of BMP in PCF seems to have a less important effect on clinical and radiological outcomes.